Literature DB >> 30046229

MAT1 correlates with molecular subtypes and predicts poor survival in breast cancer.

Hanxiao Xu1, Xianguang Bai2, Shengnan Yu1, Qian Liu1, Richard G Pestell3, Kongming Wu1.   

Abstract

OBJECTIVE: Menage a trois 1 (MAT1) is a targeting subunit of cyclin-dependent kinase-activating kinase and general transcription factor IIH kinase, which modulates cell cycle, transcription and DNA repair. Its dysregulation is responsible for diseases including cancers. To further explore the role of MAT1 in breast cancer, we investigated the pathways in which MAT1 might be involved, the association between MAT1 and molecular subtypes, and the role of MAT1 in clinical outcomes of breast cancer patients.
METHODS: We conducted immunohistochemistry staining on tissue microarray and immunofluorescence staining on sections of MAT1 stable breast cancer cells. Also, we performed Kyoto Encyclopedia of Genes and Genomes pathway analysis, correlation analysis and prognosis analysis on public databases.
RESULTS: MAT1 was involved in multiple pathways including normal physiology signaling and disease-related signaling. Furthermore, MAT1 positively correlated with the protein status of estrogen receptor and progesterone receptor, and was enriched in luminal-type and human epidermal growth factor receptor 2-enriched breast cancer in comparison with basal-like subtype at both mRNA and protein levels. Correlation analysis revealed significant association between MAT1 mRNA amount and epithelial markers, mesenchymal markers, cancer stem cell markers, apoptosis markers, transcription markers and oncogenes. Consistently, the results of immunofluorescence stain indicated that MAT1 overexpression enhanced the protein abundance of epidermal growth factor receptor, vimentin, sex determining region Y-box 2 and sine oculis homeobox homolog 1. Importantly, Kaplan-Meier Plotter analysis reflected that MAT1 could serve as a prognostic biomarker predicting worse relapse-free survival and metastasis-free survival.
CONCLUSIONS: MAT1 is correlated with molecular subtypes and is associated with unfavorable prognosis for breast cancer patients.

Entities:  

Keywords:  Menage a trois 1 (MAT1); breast cancer; molecular subtypes; prognosis; proliferation

Year:  2018        PMID: 30046229      PMCID: PMC6037588          DOI: 10.21147/j.issn.1000-9604.2018.03.07

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  35 in total

Review 1.  The multiple roles of transcription/repair factor TFIIH.

Authors:  J Q Svejstrup; P Vichi; J M Egly
Journal:  Trends Biochem Sci       Date:  1996-09       Impact factor: 13.807

2.  Analysis of recombinant phosphoprotein complexes with complementary mass spectrometry approaches.

Authors:  Laetitia Fouillen; Wassim Abdulrahman; Dino Moras; Alain Van Dorsselaer; Arnaud Poterszman; Sarah Sanglier-Cianférani
Journal:  Anal Biochem       Date:  2010-08-03       Impact factor: 3.365

3.  ras p21 expression in the progression of breast cancer.

Authors:  F B Fromowitz; M V Viola; S Chao; S Oravez; Y Mishriki; G Finkel; R Grimson; J Lundy
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

4.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

5.  Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.

Authors:  E J Kap; P Seibold; S Richter; D Scherer; N Habermann; Y Balavarca; L Jansen; N Becker; K Pfütze; O Popanda; M Hoffmeister; A Ulrich; A Benner; C M Ulrich; B Burwinkel; H Brenner; J Chang-Claude
Journal:  Pharmacogenomics J       Date:  2015-03-17       Impact factor: 3.550

6.  [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].

Authors:  Jian-ping Liu; Shi-zhen Yuan; Shi-neng Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2007-10-16

7.  Requirement of TFIIH kinase subunit Mat1 for RNA Pol II C-terminal domain Ser5 phosphorylation, transcription and mRNA turnover.

Authors:  Katja Helenius; Ying Yang; Timofey V Tselykh; Heli K J Pessa; Mikko J Frilander; Tomi P Mäkelä
Journal:  Nucleic Acids Res       Date:  2011-03-08       Impact factor: 16.971

8.  DACH1 suppresses breast cancer as a negative regulator of CD44.

Authors:  Hanxiao Xu; Shengnan Yu; Xun Yuan; Jing Xiong; Dong Kuang; Richard G Pestell; Kongming Wu
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

Review 9.  Chimeric antigen receptor T cells: a novel therapy for solid tumors.

Authors:  Shengnan Yu; Anping Li; Qian Liu; Tengfei Li; Xun Yuan; Xinwei Han; Kongming Wu
Journal:  J Hematol Oncol       Date:  2017-03-29       Impact factor: 17.388

Review 10.  Recent advances of highly selective CDK4/6 inhibitors in breast cancer.

Authors:  Hanxiao Xu; Shengnan Yu; Qian Liu; Xun Yuan; Sridhar Mani; Richard G Pestell; Kongming Wu
Journal:  J Hematol Oncol       Date:  2017-04-24       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.